Bayer shares slightly lower despite study success in prostate cancer with Xofigo combination therapy
Bayer has achieved clinical trial success in the treatment of prostate cancer with a combination therapy of its drug Xofigo. Xofigo is a so-called “alpha radiopharmaceutical” with the active ingredient…
